Skip to main content
MREO logo

MREO · Mereo BioPharma Group plc · Short Interest

Track MREO — free
$0.28 +0.04 (+14.47%) At close · Sep 11
Market Cap
$44.71M
Shares
159.69M

Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.

MREO Latest Reported Short Interest

FINRA reported 3,764,977 MREO shares sold short as of the August 31, 2026 settlement date, a decrease of 551,288 shares. Days to cover was 3.42 based on FINRA's reported average daily volume.

Official FINRA short-interest data · share counts are restated for subsequent splits of this listing

MREO Short Interest Forecast

Equibles' model estimates 3,741,677 shares sold short for the September 15, 2026 settlement, -0.6% versus the latest reported position, with a likely range of 2,918,865 to 4,725,952 shares. This model prediction uses FINRA data through September 11, 2026; FINRA's official release is expected September 24, 2026.

Model estimate

Expected Sep 15 short interest

as of Sep 11 Low confidence 50% chance it rises
3,741,677 -0.6% vs reported
Likely range 2,918,865 to 4,725,952 The latest estimate appears in the chart below. Official release expected Sep 24. Methodology
Short Squeeze Score
39/100
Short interest 2.4% of shares — P52 Days to cover 3.4 — P50 Price vs VWAP -7.9% — P32 Short-volume trend -3.9% — P34 Short interest change -12.8% — P18 Worst FTD 0.00% of shares — P15

Positioning score 38.8 + catalyst boost 0 (total capped at 100). This is a screening index, not a probability of a squeeze.

Method and coverage limits

Factor percentiles compare eligible primary operating-company stocks reporting short interest at the latest settlement date (2026-08-31). The weighted mean uses short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, and fails-to-deliver 10%. Missing factors redistribute their weight; incomplete coverage is not evidence of low risk. Price, volume, and earnings boosts add 10 each, capped at 20.

Shares outstanding are not free float. Borrow fees, utilization, lendable supply, recalls, and dealer inventory are not measured. Short-sale volume does not measure the change in open shorts; fails to deliver are not a borrow-cost measurement; price vs VWAP does not establish short sellers' entry prices. Earnings can move prices in either direction.

The weights are judgment-based, not calibrated to future squeeze outcomes. The separate options assessment below does not change this universe ranking.

Options positioning & squeeze sensitivity

Nearest expiration after today within 30 calendar days; same-day expirations and later maturities are excluded.

Expiration 2026-09-18 · Open interest as of 2026-09-10

Call / put open contracts
1,212 / 30
Put/call ratio 0.02
Calls within ±10% of spot
0 shares
0.0 % of call share equivalents
Near-money calls / daily volume
0.00×
Gross share equivalents, not shares to buy
Gross gamma · 1% stock move
— of daily volume
— shares of local delta sensitivity

Reference stock price 0.28 as of 2026-09-11. Average daily volume 1,419,163, over 20 consecutive trading sessions through 2026-09-11. A dash means the required data is unavailable.

Open interest has both a buyer and a seller; it does not reveal dealer hedge direction. Gross gamma sums both calls and puts without netting and uses a local 1% price-change approximation. It measures sensitivity, not predicted buying or a squeeze probability.

Assessment prepared 2026-09-13 10:07 UTC. Options model values may come from a cached snapshot; their original computation time is not supplied. Open interest has its own effective date.

Short Interest History

Settlement Date Current Position Previous Position Change Days to Cover
2026-09-30 Scheduled
FINRA publishes Oct 9
2026-09-15 Scheduled
FINRA publishes Sep 24
2026-08-31 3,764,977 4,316,265 -551,288 3.42
2026-08-14 4,316,265 3,413,324 +902,941 1.00
2026-07-31 3,413,324 3,535,905 -122,581 3.36
2026-07-15 3,535,905 5,883,564 -2,347,659 3.23
2026-06-30 5,883,564 5,347,606 +535,958 3.18
2026-06-15 5,347,606 8,160,044 -2,812,438 1.55
2026-05-29 8,160,044 5,683,903 +2,476,141 1.00
2026-05-15 5,683,903 6,508,278 -824,375 3.14
2026-04-30 6,508,278 8,267,481 -1,759,203 4.42
2026-04-15 8,267,481 10,907,448 -2,639,967 4.84
2026-03-31 10,907,448 11,262,015 -354,567 7.70
2026-03-13 11,262,015 13,764,845 -2,502,830 7.85
2026-02-27 13,764,845 14,093,360 -328,515 5.38
2026-02-13 14,093,360 13,042,775 +1,050,585 3.92
2026-01-30 13,042,775 9,814,341 +3,228,434 1.50
2026-01-15 9,814,341 10,517,934 -703,593 1.00
2025-12-31 10,517,934 9,785,445 +732,489 1.00
2025-12-15 9,785,445 9,207,930 +577,515 3.35
2025-11-28 9,207,930 9,249,501 -41,571 7.22
2025-11-14 9,249,501 10,121,542 -872,041 6.44
2025-10-31 10,121,542 11,162,287 -1,040,745 6.12
2025-10-15 11,162,287 11,561,612 -399,325 7.55
2025-09-30 11,561,612 11,042,078 +519,534 10.69
2025-09-15 11,042,078 11,292,464 -250,386 10.97

Full FINRA short interest reporting calendar

Showing 1–24 of 24 settlements
Key facts CIK 1719714 CUSIP 589492107 13F (30d) 24 filings 24 filers Visit website Investor relations